Inna M Chen
Overview
Explore the profile of Inna M Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rechner L, Felter M, Bekke S, Biancardo S, Ronjom M, Pedersen M, et al.
Cureus
. 2024 Oct;
16(9):e68386.
PMID: 39355470
Pancreatic cancer is one of the most challenging tumor sites to treat safely and effectively with radiotherapy due to the anatomical location and aggressiveness of the disease. One modality that...
2.
Markussen A, Johansen J, Larsen F, Theile S, Hasselby J, Willemoe G, et al.
Clin Cancer Res
. 2024 Jun;
30(16):3428-3437.
PMID: 38874506
Purpose: The purpose of this study was to evaluate the clinical benefits of nivolumab with/without ipilimumab combined with stereotactic body radiotherapy (SBRT) in patients with pretreated metastatic biliary tract cancer...
3.
Genovese F, Bager C, Frederiksen P, Vazquez D, Sand J, Gisli Jenkins R, et al.
Matrix Biol
. 2024 Jun;
132:1-9.
PMID: 38871093
Fibrosis, driven by fibroblast activities, is an important contributor to morbidity and mortality in most chronic diseases. Endotrophin, a signaling molecule derived from processing of type VI collagen by highly...
4.
Hjaltelin J, Novitski S, Jorgensen I, Siggaard T, Vulpius S, Westergaard D, et al.
Elife
. 2023 Nov;
12.
PMID: 37988407
Pancreatic cancer is one of the deadliest cancer types with poor treatment options. Better detection of early symptoms and relevant disease correlations could improve pancreatic cancer prognosis. In this retrospective...
5.
Johansen A, Novitski S, Hjaltelin J, Theile S, Boisen M, Brunak S, et al.
Front Immunol
. 2023 Sep;
14:1228907.
PMID: 37744345
Background: YKL-40, also known as chitinase-3-like protein 1 (CHI3L1), is a secreted glycoprotein produced by various cell types including stromal, immune, and cancer cells. It contributes to cancer progression through...
6.
Rasmussen L, Winther S, Chen I, Weber B, Ventzel L, Liposits G, et al.
BMC Cancer
. 2023 Jun;
23(1):552.
PMID: 37328835
Background: According to current evidence, the best treatment for fit patients with non-resectable pancreatic cancer (PC) is combination chemotherapy, whereas frail patients are recommended gemcitabine (Gem) monotherapy. Randomized controlled trials...
7.
Nissen N, Johansen A, Chen I, Jensen C, Madsen E, Hansen C, et al.
Front Mol Biosci
. 2023 Mar;
10:1158058.
PMID: 36968276
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a pronounced fibrotic tumor microenvironment, which impairs treatment response. Type I and V collagens are responsible for the densely packed fibrils in the...
8.
Mortensen R, Holmstrom M, Landkildehus Lisle T, Hasselby J, Willemoe G, Met O, et al.
J Immunother Cancer
. 2023 Mar;
11(3).
PMID: 36948507
Background: Circulating transforming growth factor-β (TGF-β)-specific T cells that recognize TGF-β-expressing immune regulatory cells have been described in patients with cancer. TGF-β-derived peptide vaccination modulates the tumor microenvironment and has...
9.
Christensen T, Madsen K, Maag E, Larsen O, Jensen L, Hansen C, et al.
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831406
Biliary tract cancer (BTC) is a rare gastrointestinal cancer with a dismal prognosis. Biomarkers with clinical utility are needed. In this study, we investigated the association between survival and 89...
10.
Stuhr L, Madsen K, Johansen A, Chen I, Hansen C, Jensen L, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765852
The objective of this study was to evaluate the diagnostic and prognostic potential of soluble CD163 (sCD163) in patients with pancreatic ductal adenocarcinoma (PDAC). Preoperative serum samples from 255 patients...